Quest Diagnostics (DGX)

• Market cap: $19.9B
• 1 day: -0.16%
• 5 days: 2.50%
• 1 month: 5.33%
• 3 months: 8.56%
• 6 months: 14.29%
• Year to date: 18.06%
• 1 year: 28.98%
• 5 years: 61.86%
• 10 years: 149.54%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: Quest Diagnostics Inc is a leading independent provider of diagnostic testing, information, and services in the us. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Employees: 56,000

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

103% more first-time investments, than exits

New positions opened: 120 | Existing positions closed: 59

81% more call options, than puts

Call options by funds: $63.1M | Put options by funds: $35M

5% more funds holding

Funds holding: 832 [Q3] → 874 (+42) [Q4]

2.31% more ownership

Funds ownership: 86.15% [Q3] → 88.46% (+2.31%) [Q4]

5% more repeat investments, than reductions

Existing positions increased: 306 | Existing positions reduced: 292

0% more capital invested

Capital invested by funds: $14.9B [Q3] → $14.9B (+$23.3M) [Q4]

50% less funds holding in top 10

Funds holding in top 10: 2 [Q3] → 1 (-1) [Q4]

Research analyst outlook

10 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $170 5% downside
• Avg. target: $187 5% upside
• High target: $200 12% upside

10 analyst ratings

• positive: 3 30%
• neutral: 7 70%
• negative: 0 0%

Piper Sandler David Westenberg 45% 1-year accuracy 19 / 42 met price target	12% upside $200	Neutral Maintained	28 Apr 2025
Truist Securities David Macdonald 54% 1-year accuracy 55 / 101 met price target	7% upside $190	Hold Maintained	23 Apr 2025
Barclays Stephanie Davis 57% 1-year accuracy 8 / 14 met price target	4% upside $185	Equal-Weight Maintained	23 Apr 2025
Evercore ISI Group Elizabeth Anderson 42% 1-year accuracy 14 / 33 met price target	1% upside $180	In-Line Maintained	23 Apr 2025
Baird Eric Coldwell 45% 1-year accuracy 14 / 31 met price target	9% upside $194	Outperform Maintained	23 Apr 2025